The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Determine the impact of hybrid capture-based comprehensive genomic profiling (CGP) on the treatment strategies in patients with solid tumors: A national, multicenter, retrospective study.
 
Umut Disel
No Relationships to Disclose
 
Fatih Kose
No Relationships to Disclose
 
Ahmet Bilici
No Relationships to Disclose
 
Mustafa Özgüroğlu
No Relationships to Disclose
 
Sezer Saglam
No Relationships to Disclose
 
Mesut Seker
No Relationships to Disclose
 
Sercan Aksoy
Honoraria - Lilly; Pfizer; Roche
Travel, Accommodations, Expenses - Astellas Pharma; BMS Turkey
 
Ibrahim Tek
Employment - Gen (I)
Stock and Other Ownership Interests - BMS Turkey (I)
Honoraria - Eczacibasi Baxter
Consulting or Advisory Role - Amgen; Janssen; Roche
Travel, Accommodations, Expenses - Astellas Amgen BioPharama
 
Yesim Eralp
Consulting or Advisory Role - Novartis; Roche
Travel, Accommodations, Expenses - Novartis; Pfizer; Roche
 
Nil Molinas Mandel
No Relationships to Disclose
 
Gokhan Demir
Honoraria - Roche
Consulting or Advisory Role - AstraZeneca; Roche
 
Cagatay Arslan
No Relationships to Disclose
 
Mutlu Demiray
No Relationships to Disclose
 
Taflan Salepci
No Relationships to Disclose
 
Mehmet Akif Ozturk
Honoraria - Novartis; Pfizer
Travel, Accommodations, Expenses - Novartis; Pfizer
 
Fatih Selcukbiricik
No Relationships to Disclose
 
Gokce Temizas
Employment - Foundation One Inc
Leadership - Foundation One Inc
 
Ebru Gul Fidan
Employment - Foundation One Inc
Stock and Other Ownership Interests - Roche